StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$2.02−0.02 (-0.98%)

Close on Nov 17, 2026Market cap $191.00MP/E 5.3Yield –

Compugen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Compugen's market cap was $197.97M on Nov 11, 2026, against $145.92M a year earlier. Over the last 5 years it ranged from $51.11M to $360.85M, with a median of $159.38M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$197.97M+38.3%
2025Dec 31, 2025$143.11M+4.5%
2024Dec 31, 2024$136.98M-21.6%
2023Dec 29, 2023$174.70M+181.8%
2022Dec 30, 2022$62.00M-82.8%
2021Dec 31, 2021$360.85M-64.0%
2020Dec 31, 2020$1.00B+171.2%
2019Dec 31, 2019$369.26M+197.5%
2018Dec 31, 2018$124.12M-2.9%
2017Dec 29, 2017$127.83M-50.8%
2016Dec 30, 2016$259.63M-19.5%
2015Dec 31, 2015$322.44M-20.1%
2014Dec 31, 2014$403.74M+17.6%
2013Dec 31, 2013$343.33M+93.9%
2012Dec 31, 2012$177.07M+5.5%
2011Dec 30, 2011$167.88M+3.8%
2010Dec 31, 2010$161.71M–

More Compugen figures

See a number that looks wrong?